Sex bias in response to hepatitis B vaccination in end-stage renal disease patients: Meta-analysis

Table 3 Vaccination information details in the included clinical trials

Author	Ref.	Vaccination mode	Vaccine type	Vaccine dose	Schedule (mo)
Abdul N Khan	[7]	IM	Recombinant (Engerix-B)	40 mcg	0, 1, (2), 6
Kai Ming Chow	[8]	IM	Recombinant (Engerix-B)	40 mcg and 80 mcg	0, 1, 6
Ismail Hamdi Kara	[9]	IM	Recombinant (Engerix-B)	40 mcg	0, 1, 2, 6
Baris Afsar	[10]	IM	Recombinant	-	0, 1, 2, 6
Andre F Charest	[11]	ID and IM	Recombinant (Engerix-B)	40 mcg (IM); 5 mcg (ID)	0, 1, 2, 6
Yao-Lung Liu	[12]	IM	Recombinant (Engerix-B)	40 mcg	0, 1, 2, 6
Nancy M Waite	[13]	IM	Recombinant (Engerix-B)	40 mcg	0,1,2,6
Salwa Ibrahim	[14]	IM	Recombinant (Engerix-B)	40 mcg	0, 1, 2, 6
Shih-Yi Lin	[15]	IM	Recombinant (Engerix-B)	40 mcg	0, 1, 2, 6
Dede sit	[16]	IM	Recombinant (Hepavax)	40 mcg	0, 1, 2, 6
Gerald DaRoza	[17]	IM	Recombinant and plasma derived	20, 40 and 80 mcg	0, 1, 6
Jamshid Roozbeh	[18]	IM and ID	Recombinant (Herberbiovac-HB)	40 mcg (IM); 20 mcg (ID)	0, 1, 4
Khalid Al Saran	[19]	IM	Recombinant (Engerix-B)	40 mcg	0, 1, 2, 6
Kevin S Eardley	[20]	IM	Recombinant (Aventis MSD)	40 mcg	0, 1, 2, 12
Sabahattin Ocak	[21]	IM	Recombinant (Euvax-B)	40 mcg	0, 1, 2, 6
EO Morais	[22]	ID	Recombinant (Greencross)	2 × 5 mcg	16 injection within 8 wk
Sh Taheri	[23]	IM	Recombinant (Havana)	40 mcg	0, 1, 6
Carol Dacko	[24]	IM	Recombinant (Engerix)	40 mcg	0, 1, 2, 6
Gerald M Fraser	[25]	NA	Recombinant (Engerix-B)	20 mcg	0, 1, 2, 6

ID: Intra-dermal; IM: Intramuscular.